Newsfeeds - Spark Newswire

1 minute read

FDA Declines MannKind – United Therapeutics’ Formulated Treprostinil For Lung Disease

Today, 4:35 PM

The FDA has issued a complete response to United Therapeutics Corporation (NASDAQ:UTHR) regarding the marketing application for Tyvaso DPI for pulmonary arterial…

MNKD

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 4:35 PM

ADMP

3 minute read

FDA
News

United Therapeutics Provides An Update On The Progress Of The Tyvaso DPI New Drug Application

By Benzinga Newsdesk

Today, 4:35 PM

United Therapeutics Corporation (NASDAQ: UTHR) today announced an update on the U.S.

MNKD

7 minute read

Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates

By Shanthi Rexaline

Today, 4:35 PM

Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned.

ANIP

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 4:35 PM

Gainers

APRE

1 minute read

News

Mannkind Corporation Announces Sale-Leaseback Transaction Generating $102.25M In Non-Dilutive Gross Proceeds

By Benzinga Newsdesk

Today, 4:35 PM

MannKind Corporation (NASDAQ:MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases, announced today that it has entered

MNKD

2 minute read

Earnings

MannKind’s Return On Capital Employed Overview

By Benzinga Insights

Today, 4:35 PM

According to Benzinga Pro data, during Q2, MannKind (NASDAQ:MNKD) posted sales of $23.28 million. Earnings were up 9.95%, but MannKind still reported an overall loss of $9.03 million.

MNKD

1 minute read

United Therapeutics-MannKind’s Formulated Tyvaso Shows Benefit In Pulmonary Hypertension Patients

By Vandana Singh

Today, 4:35 PM

United Therapeutics Corporation (NASDAQ: UTHR) has

MNKD

1 minute read

News

MannKind Files For U.S. Patent Application Titled ‘DRY POWDER DRUG DELIVERY SYSTEM’

By Michael Horton

Today, 4:35 PM

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6226&p=125&f=G&l=50&d=PG01&S1=20210812.PD.&OS=PD/20210812&RS=PD/20210812

MNKD

1 minute read

News

MannKind Files For U.S. Patent Application Titled ‘Use of Ultrarapid Acting Insulin’

By Michael Horton

Today, 4:35 PM

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6323&p=127&f=G&l=50&d=PG01&S1=20210812.PD.&OS=PD/20210812&RS=PD/20210812

MNKD